Merck & Co. Inc. (MRK) reported a profit for the first quarter of 2018 that declined 53 percent from last year, hurt by a $1.4 billion aggregate charge related to the formation of a collaboration with Eisai Co. Merck lowered 2018 earnings per share outlook, but raised adjusted earnings per share and revenue guidance. Meanwhile, Pfizer posted a 14 percent increase in profit for the first quarter.
from RTT - Earnings https://ift.tt/2I7kgha
via IFTTT
No comments:
Post a Comment